CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- 4 Grant or award Chief Commercial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 20,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Technical Officer acquired 20,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 20,000 shares (grant or award)
- 4 Other disposition 10% owner disposed of 1,250,000 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
Page 21 of 33 · 660 filings